Pain Management of Pecto-intercostal Fascial Block Versus Intravenous Fentanyl After Pediatric Cardiac Surgery

Sponsor
Mansoura University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04945694
Collaborator
(none)
80
1
2
12
6.7

Study Details

Study Description

Brief Summary

Cardiac surgical patients often experience significant postoperative pain at the median sternotomy site.

In pediatric cardiac surgery, the recommended pre bypass dose of fentanyl to blunt the hemodynamic and metabolic stress response is 25-50 µg/kg Today lower doses are often used in order to achieve early extubation at such doses there is no guarantee that the stress response is completely abolished one way to overcome this problem is the use of the local anesthetic technique Regional anesthetic techniques reduce pain for up to 24 hours after cardiac surgery in children.

Pectointercostal fascial block was first described by de la Torre in patients undergoing breast surgery. This novel technique blocks the anterior cutaneous nerve which is a branch of the intercostal nerve that gives sensory supply to the skin.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

The aim of the current study is to detect the effectiveness of pecto-intercostal fascial block in relieving postoperative pain in noncyanotic pediatric patients undergoing elective cardiac surgery the primary goal of this randomized study is to compare the postoperative pain score in the first postoperative 24 hours and to detect total dose of fentanyl requirements. The secondary goals are intraoperative hemodynamic stress response to surgical stimuli, analgesic consumption in the studied groups, cross-clamping and bypass time, time to extubation, intensive care length of stay, and postoperative complications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Ultrasound-Guided Bilateral Pecto-intercostal Fascial Block Versus Intravenous Fentanyl for Postoperative Pain Management After Pediatric Cardiac Surgery A Prospective, Randomized, Controlled Study
Anticipated Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ultrasound-guided bilateral pecto-intercostal fascial block

Patients will receive bilateral ultrasound-guided pecto-intercostal fascial block

Other: Ultrasound-guided bilateral pecto-intercostal fascial block
- PATIENT IN SUPINE POSITION, SKIN WILL BE DISINFECTED, A HIGH-FREQUENCY LINEAR PROBE WILL BE PLACED PARALLEL TO LONGITUDINAL AXIS OF STERNUM ON LATERAL BORDER AND SCANNED LATERALLY TO IDENTIFY 4TH AND 5TH COSTAL CARTILAGE. THE PECTORALIS MAJOR MUSCLE (PMM), INTERNAL INTERCOSTAL MUSCLE (IIM), TRANSVERSUS THORACIS MUSCLE (TTM), RIBS, AND PLEURA WILL BE IDENTIFIED. COLOR DOPPLER ULTRASONOGRAPHY WILL BE USED TO DETERMINE PERFORATING BRANCHES OF INTERNAL THORACIC ARTERY, WHICH TRAVEL ANTERIORLY THROUGH THE ANTERIOR CHEST WALL, PIERCING THE INTERCOSTAL MUSCLE AND PMM. A 22G NEEDLE WILL BE INSERTED IN PLANE WITH PROBE, IN CAUDAL-TO-CRANIAL DIRECTION UNTIL THE TIP IS POSITIONED IN INTER- FASCIAL PLANE BETWEEN THE PMM AND IIM. NORMAL SALINE WILL BE USED TO DETERMINE CORRECT PLACEMENT OF NEEDLE TIP IN INTER-FASCIAL PLANE, AS SHOWN BY SEPARATION OF FASCIAL LAYERS THEN LOCAL ANESTHETIC WILL BE INJECTED

Drug: Propofol
Propofol anesthesia

Drug: Sevoflurane
Sevoflurane anesthesia

Drug: Atracurium
Intravenous atracurium

Device: ultrasound
ultrasound-guided block

Placebo Comparator: Intravenous fentanyl

Patients will receive only incremental doses of intravenous fentanyl

Drug: Intravenous fentanyl
In this group, patients will receive only incremental doses of intravenous fentanyl

Drug: Propofol
Propofol anesthesia

Drug: Sevoflurane
Sevoflurane anesthesia

Drug: Atracurium
Intravenous atracurium

Outcome Measures

Primary Outcome Measures

  1. Postoperative pain assessment [Postoperative day 1]

    Postoperative pain will be assessed using the modified objective pain score (OPDS) in children.

  2. Total dose of fentanyl requirements [intraoperative and 24 hrs postoperatively]

    Total dose of fentanyl requirements

Secondary Outcome Measures

  1. Serum cortisol levels [Basal and one-hour postoperatively]

  2. Heart rate [HR] [before induction of anesthesia (basal value), after induction of anesthesia, after skin incision, after sternotomy, 15 min after CPB and after the closure of sternum]

  3. Invasive mean arterial blood pressure [MAP] [before induction of anesthesia (basal value), after induction of anesthesia, after skin incision, after sternotomy, 15 min after CPB and after the closure of sternum]

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • On pump

  • Elective repair of congenital simple left to right intracardiac shunt

  • Median sternotomy

Exclusion Criteria:
  • Refusal of their guardians

  • Redo cardiac surgery

  • Previous back injury

  • Previous back surgery

  • Kyphoscoliosis

  • Local infection of the skin and subcutaneous tissue at the site of needle puncture

  • Hypersensitivity to local anesthetics

  • Coagulation disorders

  • Renal disease

  • Hepatic disease

  • Pulmonary disease

  • Heart failure

  • Moderate to severe pulmonary hypertension.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mansoura University Mansoura DK Egypt 050

Sponsors and Collaborators

  • Mansoura University

Investigators

  • Study Director: Mohamed A Ghanem, MD, Assistant professor, MD anesthesia Department, Faculty of Medicine, Mansoura University, Egypt
  • Study Chair: Enas Abd Elmotlb, MD, professor, MD anesthesia Department, Faculty of Medicine, Mansoura University, Egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mansoura University
ClinicalTrials.gov Identifier:
NCT04945694
Other Study ID Numbers:
  • MD/ 21.04.462
First Posted:
Jun 30, 2021
Last Update Posted:
Jun 30, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2021